Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: Corrective and preventive actions GMP

How to Address Non-Conformities in GMP Compliance in Asia

Posted on May 15, 2025 By digi

How to Address Non-Conformities in GMP Compliance in Asia Expert Guide to Addressing Non-Conformities in GMP Compliance Across Asia Introduction to GMP Non-Conformities Good Manufacturing Practices (GMP) are essential for ensuring the quality, safety, and efficacy of pharmaceutical products. Non-conformities in GMP compliance—whether minor or critical—can disrupt operations, delay regulatory approvals, and compromise product quality….

Read More “How to Address Non-Conformities in GMP Compliance in Asia” »

GMP in Asia (PMDA, NMPA, KFDA)

How to Integrate GMP with Your Pharmaceutical Quality Management System in North America

Posted on May 15, 2025 By digi

How to Integrate GMP with Your Pharmaceutical Quality Management System in North America Step-by-Step Guide to Integrating GMP into Your Pharmaceutical QMS Introduction to GMP and Pharmaceutical Quality Management Systems Good Manufacturing Practices (GMP) are essential for ensuring the safety, quality, and efficacy of pharmaceutical products. A robust Quality Management System (QMS) is critical for…

Read More “How to Integrate GMP with Your Pharmaceutical Quality Management System in North America” »

GMP in North America (FDA, Health Canada)

How to Align GMP Regulations in Asia with Global Standards for Pharma Compliance

Posted on May 15, 2025 By digi

How to Align GMP Regulations in Asia with Global Standards for Pharma Compliance Practical Tips for Aligning Asian GMP Regulations with Global Pharmaceutical Standards Introduction to GMP Alignment in Asia The pharmaceutical industry operates under stringent Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of drugs. While regulatory frameworks in Asia, such…

Read More “How to Align GMP Regulations in Asia with Global Standards for Pharma Compliance” »

GMP in Asia (PMDA, NMPA, KFDA)

FDA and Health Canada: How GMP Compliance Ensures Patient Safety in Pharma

Posted on May 15, 2025 By digi

FDA and Health Canada: How GMP Compliance Ensures Patient Safety in Pharma How GMP Compliance Protects Patient Safety in the Pharmaceutical Industry Introduction to GMP and Patient Safety Ensuring patient safety is the cornerstone of pharmaceutical manufacturing. Regulatory agencies like the Food and Drug Administration (FDA) in the United States and Health Canada in Canada…

Read More “FDA and Health Canada: How GMP Compliance Ensures Patient Safety in Pharma” »

GMP in North America (FDA, Health Canada)

The Role of GMP in Achieving Regulatory Approval for Drugs in Japan, China, and South Korea

Posted on May 15, 2025 By digi

The Role of GMP in Achieving Regulatory Approval for Drugs in Japan, China, and South Korea A Step-by-Step Guide to Using GMP for Regulatory Drug Approvals in Asia Introduction to GMP and Regulatory Approvals Good Manufacturing Practices (GMP) form the foundation of regulatory compliance for pharmaceutical manufacturing. In Asia, regulatory authorities like Japan’s Pharmaceuticals and…

Read More “The Role of GMP in Achieving Regulatory Approval for Drugs in Japan, China, and South Korea” »

GMP in Asia (PMDA, NMPA, KFDA)

The Role of Equipment Qualification in FDA GMP Compliance

Posted on May 15, 2025 By digi

The Role of Equipment Qualification in FDA GMP Compliance A Complete Guide to Equipment Qualification in FDA GMP Compliance Introduction to Equipment Qualification in GMP Compliance In pharmaceutical manufacturing, maintaining Good Manufacturing Practices (GMP) compliance is essential for ensuring the quality, safety, and efficacy of drug products. A critical aspect of GMP compliance, enforced by…

Read More “The Role of Equipment Qualification in FDA GMP Compliance” »

GMP in North America (FDA, Health Canada)

GMP Compliance for Pharmaceutical Manufacturing Plants in North America

Posted on May 15, 2025 By digi

GMP Compliance for Pharmaceutical Manufacturing Plants in North America Ensuring GMP Compliance in Pharmaceutical Manufacturing Plants Across North America Introduction to GMP Compliance in North America Pharmaceutical manufacturing plants in North America must adhere to stringent Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of drug products. Regulatory agencies such as the…

Read More “GMP Compliance for Pharmaceutical Manufacturing Plants in North America” »

GMP in North America (FDA, Health Canada)

The Importance of Regulatory Training for GMP Compliance in Pharma

Posted on May 15, 2025 By digi

The Importance of Regulatory Training for GMP Compliance in Pharma Why Regulatory Training is Essential for GMP Compliance in the Pharmaceutical Industry Introduction to Regulatory Training in GMP Compliance In the highly regulated pharmaceutical industry, maintaining Good Manufacturing Practices (GMP) compliance is critical to ensuring the safety, efficacy, and quality of drug products. One of…

Read More “The Importance of Regulatory Training for GMP Compliance in Pharma” »

GMP in North America (FDA, Health Canada)

How to Navigate FDA and Health Canada’s GMP Guidelines for Global Pharmaceutical Markets

Posted on May 15, 2025 By digi

How to Navigate FDA and Health Canada’s GMP Guidelines for Global Pharmaceutical Markets A Comprehensive Guide to Navigating FDA and Health Canada’s GMP Guidelines for Global Markets Introduction to GMP Compliance for Global Pharmaceutical Markets As pharmaceutical companies expand into global markets, compliance with Good Manufacturing Practices (GMP) becomes increasingly complex. Regulatory frameworks enforced by…

Read More “How to Navigate FDA and Health Canada’s GMP Guidelines for Global Pharmaceutical Markets” »

GMP in North America (FDA, Health Canada)

How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India

Posted on February 16, 2025 By digi

How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India Practical Tips for Adapting Pharmaceutical R&D Processes to Schedule M Revised Compliance Introduction to Schedule M Revised and Its Impact on R&D The updated Schedule M under the Drugs and Cosmetics Rules, 1945, has introduced stricter Good Manufacturing Practices (GMP) that affect all…

Read More “How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India” »

GMP in India

Posts pagination

Previous 1 … 6 7 8 … 26 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Use Passivation Methods to Maintain Stainless Steel Equipment Integrity

    Use Passivation Methods to Maintain… Read more

Corrective and preventive actions GMP

  • Health Canada GMP Inspection Process: What to Expect
  • The Role of GMP in Preventing Cross-Contamination in Asian Pharmaceutical Manufacturing
  • How FDA GMP Inspections Affect Pharmaceutical Manufacturing Efficiency
  • How to Maintain GMP Compliance for Pharma Products Manufactured in Asia
  • The Importance of Documentation for GMP Compliance in North America
  • How NMPA’s GMP Guidelines Influence the Production of APIs and Finished Drugs in China
  • The Role of Supplier Quality Management in FDA GMP Compliance
  • The Impact of KFDA GMP Guidelines on the South Korean Pharmaceutical Industry
  • The Relationship Between FDA GMP Regulations and Pharmaceutical Packaging
  • How to Address GMP Violations in Asian Pharmaceutical Manufacturing

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme